Financial Highlight / Main Financial Index

• Overview of Financial Results
• Financial Highlight
• Main Financial Index
• Financial forecast （full year plan）

During the first three months of the current fiscal year (May 1, 2025 to July 31, 2025), the Japanese economy recovered gradually along with an improvement in the employment and income environment. However, conditions remain uncertain due to the risk of downward pressure on the domestic economy from slowing conditions overseas, as well as rising prices, trends in trade policy and fluctuations in financial and capital markets.

Against this backdrop, in March 2025, the AIN HOLDINGS Group (the Group) announced its medium-to-longterm vision, “Ambitious Goals 2034: A decade to promote innovation and strive for our challenging goal of a trillion yen in sales.” To ensure medium-to-long-term corporate growth even in a rapidly changing market environment, we have established business-specific visions and aim to achieve net sales of ¥1 trillion, a net profit margin of 4.0%, and an ROE of 15.0% for the fiscal year ending April 2034. 

In its sustainability management, the Group worked to provide healthcare and retail services in line with its mission to “contribute to local healthcare” and “provide beauty and happiness” – two of the Group’s materiality issues. Through August 2025, we conducted healthcare and health awareness activities for local communities, such as cooperating in awareness campaigns for "Japan Heart Day 2025," co-sponsored by four organizations including the Japan Heart Foundation, and supporting initiatives by the Japan Sports Agency to improve life performance.

In recognition of these and other ongoing initiatives, the Company has been selected as a constituent of the following ESG indices for Japanese equities adopted by the Government Pension Investment Fund (GPIF), the world's largest pension fund: the FTSE Blossom Japan Sector Relative Index, the MSCI Nihonkabu ESG Select Leaders Index, the MSCI Japan Empowering Women Index (WIN), the S&P/JPX Carbon Efficient Index, and the Morningstar Japan ex-REIT Gender Diversity Tilt Index.

In the whole company, net sales reached ¥132,969 million, increased 28.3% YoY and 1.5% against the plan due to growth at existing stores and stores opened in the previous year in both businesses, as well as supported by the consolidation of Francfranc in the previous fiscal year. Ordinary profit reached ¥4,259 million, increased 43.4% YoY and 6.6% against the plan.

In the dispensing pharmacy business, net sales reached ¥108,590 million, increased 18.2% YoY and 2.2% against the plan because the number of prescriptions remained steady and average prescription price rose due to an increase in high-cost prescriptions. Segment profit was ¥4,231 million, decreased 0.3% YoY and increased 6.8% against the plan.

In the retail business, net sales reached ¥21,581 million, increased 141.2% YoY and decreased 1.8% against the plan, supported by the consolidation of Francfranc in the previous fiscal year. Segment profit reached ¥2,912 million, increased 186.6% YoY and 8.3% against the plan due to cost reduction.

Net Sales

（million yen）

Gross Profit , % of Net Sales

（million yen）

SG&A Expenses , % of Net Sales

（million yen）

Operating Profit , % of Net Sales

（million yen）

Ordinary Profit , % of Net Sales

（million yen）

Profit Attributable to Owners of Parent , % of net sales

（million yen）

Please refer to the following page for our financial forecast .